Genzyme splits revenue from Aldurazyme with BioMarin Pharmaceutical (nasdaq: BMRN - news - people ).

FORBES: Can Genzyme Defy Skeptics Again?

The U.S. Food and Drug Administration yesterday approved BioMarin's (nasdaq: BMRN - news - people ) first drug, a treatment for a rare genetic disease.

FORBES: BioMarin Gets Ready To Bloom

Biomarin (nasdaq: BMRN - news - people ) and Alexion (nasdaq: ALXN - news - people ) have launched drugs for orphan diseases.

FORBES: Genzyme Eyes Isis Drug

The next day (line 3) BMRN was down again and the RSI3 dropped below its uptrend, line c, and its WMA. The RSI3 formed lower highs, line b, which was a negative divergence.

FORBES: Using Options to Trade Double Tops

Among the largest underlying components of XBI, in trading today Biomarin Pharma ( NASD: BMRN) is up about 1.8%, Regeneron Pharmaceutical ( NASD: REGN) is up about 0.4%, and Spectrum Pharmaceuticals ( NASD: SPPI) is up by about 4%.

FORBES: Biotech Stocks Pains Continue As Outflows Persist

Among the largest underlying components of VB, in trading today BioMarin Pharmaceutical Inc. ( NASD: BMRN) is up about 0.1%, Royal Gold, Inc. ( NASD: RGLD) is up about 1.1%, and Ariba Inc. ( NASD: ARBA) is relatively unchanged.

FORBES: VB, BMRN, RGLD, ARBA: Large Outflows Detected at ETF

Among the largest underlying components of VB, in trading today BioMarin Pharmaceutical Inc. ( NASD: BMRN) is up about 1.7%, Royal Gold, Inc. ( NASD: RGLD) is up about 0.4%, and Ariba Inc. ( NASD: ARBA) is relatively unchanged.

FORBES: Notable ETF Outflow Detected - VB, BMRN, RGLD, ARBA

Among the largest underlying components of XBI, in trading today Alexion Pharmaceuticals Incorporated ( NASD: ALXN) is up about 4.6%, Regeneron Pharmaceutical Incorporated ( NASD: REGN) is down about 3.4%, and Biomarin Pharma Incorporated ( NASD: BMRN) is lower by about 0.8%.

FORBES: Exits From Biotech

Among the largest underlying components of XBI, in trading today Biomarin Pharma Incorporated ( NASD: BMRN) is up about 0.3%, Regeneron Pharmaceutical Incorporated ( NASD: REGN) is up about 0.3%, and Biogen Idec Incorporated ( NASD: BIIB) is lower by about 0.1%.

FORBES: Investors Lower Exposure To Biotech -- REGN, BIIB, BMRN In Focus

As Genzyme (nasdaq: GENZ - news - people ) did in its early days, BioMarin (nasdaq: BMRN - news - people ) focuses on drugs for rare genetic diseases, usually those in which one enzyme is defective.

FORBES: BioMarin Follows Genzyme's Playbook